Optimising RT dose for anal cancer - the development of three clinical trials in one platform
Main Authors: | Sebag-Montefiore, D, Adams, R, Bell, S, Berkman, L, Gilbert, D, Glynne-Joones, R, Goh, V, Gregory, W, Harrison, M, Kachnic, L, Lee, M, McParland, L, Muirhead, R, O'Neil, B, Hutchins, G, Rao, S, Renehan, A, Smith, A, Velikova, G, Hawkins, M |
---|---|
Format: | Conference item |
Published: |
Elsevier
2017
|
Similar Items
-
Early stage anal margin cancer: towards evidence‐based management
by: Renehan, A, et al.
Published: (2019) -
The development of an umbrella trial (PLATO) to address radiation therapy dose questions in the locoregional management of squamous cell carcinoma of the anus
by: Sebag-Montefiore, D, et al.
Published: (2016) -
Initial results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
by: Muirhead, R, et al.
Published: (2016) -
Stepwise multicenter introduction of intensity modulated radiation therapy for anal cancer in the United Kingdom: From consensus guidance to large-scale prospective audit, prior to future clinical trials
by: Gilbert, D, et al.
Published: (2016) -
Toxicity, tolerability & compliance of concurrent capecitabine or 5-fluorouracil in the radical management of anal cancer with single-dose mitomycin-C and intensity modulated radiation therapy: evaluation of a national cohort
by: Jones, C, et al.
Published: (2018)